For the year-to-date, as noted in today’s chart, NBI shows a general decline, losing more than one-fifth of its value since January. . . . → Read More: Infographic – Biotech Index Q3 Rollercoaster
|
|||||
       
 |
A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds. . . . → Read More: Start-Up Developing Efficient RNA Process, Raises $12M 
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress. . . . → Read More: Company Formed to Boost Clinical Trial Success Odds 
A start-up enterprise developing treatments for drug and alcohol addiction is raising investment capital with a direct pitch to small investors through a crowdfunding platform. . . . → Read More: Addiction Biotech Using Crowdfunding for Investments  Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, crowdfunding, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, physical sciences 
A biotechnology company designing treatments for inherited eye diseases with Crispr gene editing is raising €75 million in venture financing. . . . → Read More: Eye Disease Gene-Therapy Biotech Adds Venture Funds Comments are closed Finance, New products biomedical, biotechnology, equity, Europe, genomics, investment, life sciences, pharmaceuticals, venture capital 
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body. . . . → Read More: Cell, mRNA Therapy Biotech Raises $165M in Early Funds Comments are closed Finance, New products biomedical, biotechnology, cancer, entrepreneurs, equity, genomics, heart disease, investment, life sciences, nanotechnology, pharmaceuticals, preclinical, university, venture capital 
A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs. . . . → Read More: Venture to Build Cell, Gene Therapy Businesses One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, China, entrepreneurs, genomics, investment, licensing, life sciences, manufacturing, pharmaceuticals, stem cells 
A developer backed by a life science/real estate joint venture announced plans to create a new campus for biotechnology and related businesses in Boulder, Colorado. . . . → Read More: Biotech Business Complex Slated for Colorado Comments are closed Finance, Joint ventures/collaborations biotechnology, engineering, entrepreneurs, investment, life sciences, physical sciences, university 
A new enterprise using digital and synthetic biology to create sustainable chemicals at industrial scale is raising $5 million in pre-seed round funds. . . . → Read More: Synthetic Bio Chemicals Start-Up Gains $5M in Early Funds One comment - (Comments are closed) Finance, New products agriculture, biotechnology, carbon capture, chemistry, energy, engineering, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, mathematics, patent, physical sciences, venture capital 
A biotechnology developer of treatments for autoimmune disorders with checkpoint receptor proteins is acquired by drug maker Gilead Sciences. . . . → Read More: Immune Disease Biotech Acquired in $405M Deal One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, investment, life sciences, merger, pharmaceuticals, physical sciences, U.K., university |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
